Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class
BFT.WS
BFT.WS was delisted on the 30th of March, 2021.
50 hedge funds and large institutions have $74M invested in Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class in 2020 Q4 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$6.74M |
| 2 |
TP
Third Point
New York
|
+$3.53M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$2.46M |
| 4 |
CCM
CAAS Capital Management
New York
|
+$2.12M |
| 5 |
RCM
Ratan Capital Management
Miami Beach,
Florida
|
+$2.06M |
Top Sellers
BFT.WS Hedge Fund Activity: Q4 2020 in Review
50 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class (BFT.WS) for Q4 2020, worth a combined $74M.
Buyers outnumbered sellers: 50 funds opened new BFT.WS positions and 0 closed out — a net gain of 50 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Empyrean Capital Partners, opening a new position worth an estimated $6.74M.
- 50 institutional investors held Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class (BFT.WS) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $74M of Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class stock for Q4 2020.
- 50 funds opened new Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class positions in Q4 2020 and 0 closed out, a net change of +50 holders.
- The largest Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class buyer in Q4 2020 was Empyrean Capital Partners, an estimated $6.74M added.
Based on aggregated 13F filings for Q4 2020.